Market Overview
The South Korea Periodontal Disease Market is projected to increase from USD 125.70 million in 2023 to USD 227.84 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.60% over the forecast period.
Market expansion is primarily driven by the growing incidence of periodontal disorders, a trend linked to South Korea’s aging population and suboptimal oral hygiene habits. Heightened awareness of oral health, reinforced by government-led initiatives and public dental care campaigns, is fostering demand for effective periodontal treatments. The uptake of advanced dental technologies—including laser-based therapies and minimally invasive procedures—is improving clinical outcomes and encouraging more individuals to seek professional care. Additionally, broader access to dental insurance and enhanced reimbursement frameworks are helping to increase patient access to treatment. Industry stakeholders are investing in innovative therapeutics and digital diagnostic tools that support the rising emphasis on preventive dental care. A growing interest in cosmetic dentistry, spurred by aesthetic considerations, also contributes to market growth. Coupled with South Korea’s advanced healthcare infrastructure, these factors create a favorable environment for sustained market development in periodontal disease management.
Market Drivers
Impact of an Aging Population
The sharp increase in South Korea’s elderly population significantly influences the rising prevalence of periodontal diseases. Older adults are more susceptible to such conditions due to compromised immune systems and chronic health issues, driving demand for effective dental treatments. Research indicates that periodontal disease is one of the leading causes of medical visits among Korean adults aged 65 and above. As this demographic trend accelerates, the need for accessible, specialized dental care is expected to grow, positioning periodontal treatment as a priority area within the broader healthcare landscape.
Market Challenges Analysis
Cost and Access Limitations
The high expense associated with advanced periodontal treatments remains a major barrier to widespread care in South Korea. Innovations such as laser therapy and digital imaging, while clinically effective, often come at a premium cost, leading to treatment delays or avoidance, especially among low-income groups. Despite ongoing reforms, insurance coverage for periodontal procedures remains insufficient for many, limiting access to essential services. This financial strain intensifies disparities in oral health. Additionally, a shortage of specialized dental professionals—particularly in rural areas—restricts access to expert care. The lack of adequate dental infrastructure outside urban centers further compounds this challenge, leaving significant portions of the population underserved.
Market Segmentation
By Type:
Gingivitis
Chronic Periodontal Disease
Aggressive Periodontal Disease
Type 4
Type 5
By Application:
Non-surgical Treatment
Surgical Treatment
Application 3
Application 4
Application 5
By Therapeutics:
Systemic Antibiotics
Local Antibiotics
Therapeutics 3
Therapeutics 4
Therapeutics 5
By End Users:
Hospitals
Dental Clinics
Dental Academics
Research Institutes and Others
End Users 5
By Distribution Channel:
Distribution Channel 1
Distribution Channel 2
Distribution Channel 3
Distribution Channel 4
Distribution Channel 5
By Geography:
Seoul Metropolitan Region
Gyeonggi Province
Busan and Ulsan Regions
Key Player Analysis
Osstem Implant Co., Ltd
Dentium Co., Ltd
Neobiotech
Lyne Laboratories
Straumann Group
Dentsply Sirona Inc.
3M
BEGO GmbH & Co. KG
Biolase, Inc.
Al-Fa Perio Clinic
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook